PARA
$0.08-15.79%Delayed market dataStreamingKey levels and trade conditions
No trading signal: verified US-equity daily bars and a quote are required.
01Newstock overall assessment
The conclusion first, followed by the evidence that matters most.
ENTRY CONCLUSION
Watch — hold off on buying the dip
The valuation margin of safety, technical confirmation and market/estimate conditions are not all satisfied. No entry signal is issued.
The research does not currently establish an actionable entry price. Do not buy solely because the stock has fallen sharply; wait for the key conditions to be verified before reconsidering entry.
Why
PARA is in a high-risk mix of restructuring, financing, and continued-listing pressure: the company completed a 1-for-10 reverse split and received a Nasdaq non-compliance/delisting notice, while also closing an approximately $13.5 million financing on 2026-11-05 with about $5.512 million in net proceeds. The stock jumped sharply on 2026-11-12 on extreme volume, but that looks like event-driven volatility rather than something that offsets weak fundamentals, uncertain appeal outcomes, or further dilution risk. Disclosed terms still allow additional dilution through enlarged authorized share capacity, warrant reset features, and a zero-exercise-price option. With no reliable operating forecast basis, no valuation scenarios are constructed.
Research as of 2026-11-13T03:06:54.614Z · Research conclusion, not a real-time trading signal
02What happened recently
Company events, industry developments and market conditions — facts separated from possible explanations.
US 10Y yield 5.13%2026-11-13T17:34:34.000Z
VIX 19.762026-11-13T17:34:31.000Z
Dollar index 103.402026-11-13T17:39:33.000Z
Market and sector reference
PARA -15.25% · SPY -0.65%
2026-11-13T17:53:28.000Z · Yahoo · Aligned-session reference, not a causal attribution.
Related news and impact paths
Recent news related to this stock
0 direct · 2 2nd-order · 0 thematicRanked by model assessment and recency. Labels use the original model impact, not expected returns. Impact percentages are model estimates, not observed price changes, probabilities or guaranteed returns.
Paramount faces the same subscriber attrition and ad revenue pressure in linear TV, subject to the same sector-wide headwind.
Also named: WBD · CMCSA · DIS · NFLX
- #2Impact0.7%Adverse2nd-orderHow Bela Bajaria Is Turning Netflix Into A Live Events Powerhouse57d ago
Netflix's live-content expansion diverts advertiser budgets and sports-rights resources.
Also named: NFLX · DIS · WBD · TKO · FOXA
03Is the company worth considering?
Business quality, financials, valuation and analyst disagreements.
🏛️ Company factsSEC filings + FINRA official data
Annual revenue $12M · latest quarter down 27.3% YoY · reported FY net loss of $22M · short-sale volume share above its recent available-day average.
FY revenue
$12M
2025-12
Latest Q YoY
-27.3%
Gross margin
82%
FY net loss
$22M
Diluted EPS
$-5.95
Short-sale volume share
63.3%
2026-11-05 · Recent available-day avg 50.2% · above recent average
Short-sale volume as a share of trades covered by the FINRA file, not all market trading or outstanding short positions. Changes do not establish that short sellers are adding or covering positions.
🐋 Ownership filings (last 180 days)
Recent 13D/13G beneficial ownership filings, which may include amendments. A filing does not establish a recent purchase or a current holding, and its form type alone does not establish investment intent. Read the original filing for details.
- 2026-08-18SCHEDULE 13D/AAlco Investment Co
- 2026-08-14SCHEDULE 13GCP BF Lending, LLC
- 2026-08-03SCHEDULE 13G/AFE IV OR Aggregator, LLC
Historical results versus analyst expectations
🎯 Market expectations
Estimate context score Low · 20/100Nasdaq analyst consensus · currently available data
This data has a low context score. Analyst coverage, disagreement, or revisions may limit its usefulness. Review the estimate range and underlying data.
- Jun 2026-$30.50 vs -$29.20-4.45%
Analyst estimates, not our forecast · not investment advice
Analyst consensus and disagreement
Target-price summary $24.00–$24.00 · Consensus $24.00
Buy / hold / sell 1 / 0 / 0
Nasdaq · Retrieved 2026-11-13T17:53:29.576Z · The aggregate does not provide individual report dates or original theses. It does not establish undervaluation; no analyst rationale is inferred. Targets are not guaranteed outcomes.
Next-quarter EPS estimate (Sep 2026) $-12.20 · $-12.20–$-12.20 · 1 analysts
Four-week estimate revisions: up / down 0 / 0
Estimate dispersion 0.0%
Nasdaq EPS forecasts · retrieved 2026-11-13T17:53:29.449ZFinancial inputs and original sources
gpt-5.4-mini · 2026-11-13T03:06:54.614Z · AI-generated and checked, not an independent human audit
Cash: 5.512 USD_millions · 2026-11-05
“The Company received net proceeds of approximately $5.512 million from the Offering, after deducting the Offering expenses payable by the Company, including the Underwriter’s discounts and commissions.”
Additional equity funding: 0 USD_millions · 2026-11-05
“The Company intends to use the net proceeds from the Offering for working capital and other general corporate purposes, and repayment of indebtedness.”
04Is now a good time?
Trend, moving averages, volume and key price levels — not the decline alone.
Price and news
Historical prices and volume. Drag to pan; scroll to zoom.
Related news
05What would change our assessment?
Conditions for reconsidering entry and developments that invalidate the thesis.
When to reconsider
- The Nasdaq delisting overhang is materially resolved, and the company discloses verifiable operating improvement plus a longer post-financing cash runway.
- The stock trades stably for several sessions materially above recent lows, volume cools, and no new dilutive financing or warrant-reset announcement appears.
- Later disclosures show usable cash, debt-maturity coverage, and operating cash-flow improvement sufficient to fund the next several quarters of basic expenses.
What would invalidate the thesis
- The Nasdaq appeal/hearing fails to preserve listing, or the company cannot regain the minimum bid requirement within any extra period.
- The company does another dilutive financing, activates more warrant reset/zero-exercise-price features, or increases the share count further through the enlarged authorized share structure.
- Operating data keeps deteriorating, cash burn outpaces expectations, or the stock falls back through and fails to hold pre-event lows.
Additional risk evidence and model detail
Market View
Crowding
Risk temperature
Tail risk
Triggers
Price and volume
Insider signals
See every affected stock, second-order impact and risk factor. Try Pro free for 7 days — no credit card required.
Start my free trial